Catheter Precision, Inc. VTAK
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 380.66% | 202.10% | 59.73% | 135.42% | 127.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 380.66% | 202.10% | 59.73% | 135.42% | 127.96% |
| Cost of Revenue | 6,478.57% | 281.82% | 81.82% | 80.00% | -12.50% |
| Gross Profit | -50.51% | 195.45% | 57.97% | 141.86% | 157.14% |
| SG&A Expenses | 35.75% | -26.57% | -11.04% | 2.46% | 6.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.08% | -23.59% | -3.00% | 9.88% | 8.54% |
| Operating Income | -39.36% | 32.93% | 6.06% | -5.67% | -4.45% |
| Income Before Tax | 43.54% | 60.89% | -143.75% | 45.00% | -51.85% |
| Income Tax Expenses | 67.16% | 75.83% | -106.81% | -- | -- |
| Earnings from Continuing Operations | 39.43% | 58.22% | -3.91% | 43.11% | -29.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -96.85% | -- | -- | -- | -- |
| Net Income | 35.51% | 58.44% | -2.67% | 45.36% | -21.07% |
| EBIT | -39.36% | 32.93% | 6.06% | -5.67% | -4.45% |
| EBITDA | -51.85% | 34.60% | 7.18% | -7.04% | -7.39% |
| EPS Basic | 87.32% | 79.63% | 84.21% | 95.53% | 93.12% |
| Normalized Basic EPS | 75.51% | 89.22% | 152.39% | 95.59% | 94.60% |
| EPS Diluted | 87.32% | 79.63% | 84.21% | 95.53% | 93.12% |
| Normalized Diluted EPS | 75.51% | 89.22% | 152.39% | 95.59% | 94.60% |
| Average Basic Shares Outstanding | 294.27% | 269.05% | 239.39% | 1,122.78% | 1,659.15% |
| Average Diluted Shares Outstanding | 294.27% | 269.05% | 239.39% | 1,122.78% | 1,659.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |